Publications by authors named "Sean A Power"

Claim this Profile
U
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Sean A Power

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Edward Fox, Amy E Lovett-Racke, Matthew Gormley, Yue Liu, Maria Petracca, Sean A Power

Mult Scler· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis